Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
NCT02583438
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Obesity
Interventions
DRUG:
Saxagliptin (Bristol-Myers Squibb Company)
Sponsor
Beijing Chao Yang Hospital